… some anti-rheumatic drugs as potential treatment options for the management of COVID-19.
In … evidences on either positive or negative effect of drugs commonly used to treat RA in this …

… The antimalarial drug, hydroxychloroquine, is licensed for the chemoprophylaxis and
treatment of malaria and as a disease-modifying antirheumatic drug. It has a history of being safe …

… drugs commonly used in rheumatology like hydroxychloroquine and tocilizumab in COVID-19…
glucocorticoids and other disease-modifying antirheumatic drugs (DMARDs) in patients …

… Diseases observational registry, who answered COVID-19 web-based surveys in … US
COVID-19 pandemic. We compared medication changes by disease-modifying antirheumatic drug (…

… managing a rheumatic patient (RP) with coronavirus disease 2019 (COVID-19). This study
aims to evaluate the prevalence of COVID-19 in RPs compared to the general population and …

… disease-modifying antirheumatic drugs (bDMARDs) does not associate with severe
manifestations of COVID-19. Patients with rheumatic disease diagnosed with COVID-19 were more …

… COVID-19 vaccination. We collected patient-reported data on clinician communication, beliefs
and intent about discontinuing disease-modifying antirheumatic drugs … received COVID-19 …

… . Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases
treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin …

… Coronavirus 2”, on the other hand, antirheumatic drugs may have a protective and therapeutic
role in Coronavirus … anti-rheumatic drugs regarding the treatment of COVID-19 (Table 1). …

… COVID- 19 was developed in 7 (0.8%) patients. The data from this study showed that
medication nonadherence was not common within 6 months after the issue of COVID- 19 is widely …